Arthropathy in hypersensitivity reactions classified elsewhere

ARTHROPATHY_HYPERSENS

arthritis: An inflammatory process affecting a joint. Causes include infection, autoimmune processes, degenerative processes, and trauma. Signs and symptoms may include swelling around the affected joint and pain.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M36.4, M36.4D69.0 Cause of death: ICD-10 — M36.4, M36.4D69.0 2 out of 7 registries used, show all original rules.	48
4. Check minimum number of events None	48
5. Include endpoints None	48
6. Filter based on genotype QC (FinnGen only)	48

Control definitions (FinnGen only)

Control exclude: SYSTINOTH_FG

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	ARTHROPATHY_HYPERSENS
CONTROL_EXCLUDE	SYSTINOTH_FG
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M364
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M364
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Arthropathy in hypersensitivity reactions classified elsewhere based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	839	349	489
Only index persons	660	280	380
Unadjusted period prevalence (%)
Whole population	0.01	0.01	0.01
Only index persons	0.01	0.01	0.01
Median age at first event (years)
Whole population	8.38	8.71	8.09
Only index persons	11.65	12.89	10.73

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	48	28	20
Unadjusted period prevalence (%)	0.01	0.01	0.01
Median age at first event (years)	30.49	26.82	35.63

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

No data available

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3037522) Nuclear Ab [Titer] in Serum

21.00

26.28

1.8

1.3

613.3

272.0

titre

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

21.39

19.49

1.5

1.1

0.2

g/l

0.25

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

19.70

18.67

1.5

1.1

1.2

1.3

g/l

0.20

(3004588) Protein electrophoresis panel - Serum or Plasma

17.73

15.90

1.5

4.1

—

(42870588) Differential panel, method unspecified - Blood

112

5.99

8.60

12.0

4.5

—

(3020779) Urea [Moles/volume] in Serum or Plasma

7.82

8.40

8.9

7.2

8.2

6.9

mmol/l

0.26

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

117

5.66

8.04

10.9

2.9

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

10.26

7.88

1.4

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

19.81

7.65

1.7

1.3

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

6.03

7.47

3.8

2.2

28.6

29.1

0.23

(40768446) Kidney Pathology biopsy report

+∞

7.47

1.1

0.0

—

(3022096) Basophils/100 leukocytes in Blood

163

5.83

7.27

12.6

4.9

0.6

0.03

156

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

20.49

7.09

1.8

1.0

10.7

8.9

g/l

—

(3006504) Eosinophils/100 leukocytes in Blood

169

5.52

6.79

12.6

4.8

2.4

2.7

0.42

161

(40758558) Short blood count panel - Blood

4.79

6.75

8.7

6.4

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

17.55

6.74

1.7

1.3

0.1

0.8

g/l

—

(3019069) Monocytes/100 leukocytes in Blood

170

5.47

6.71

12.7

4.9

7.5

8.3

1.48

163

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

21.61

6.54

1.8

1.0

0.0

g/l

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

21.61

6.54

1.8

1.0

0.0

g/l

—

(3002582) Erythrocytes [#/volume] in Urine

111

4.65

6.49

10.1

2.7

34.2

51.9

e6/l

0.28

(3002621) Streptococcal DNAse B [Units/volume] in Serum

+∞

6.38

1.2

0.0

—

(3018010) Neutrophils/100 leukocytes in Blood

175

5.23

6.34

12.6

4.6

59.7

54.7

1.93

168

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

5.05

6.34

5.8

2.4

0.3

0.8

e6/l

—

(3002030) Lymphocytes/100 leukocytes in Blood

178

5.09

6.12

13.0

4.7

27.4

31.2

1.77

170

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

4.94

5.97

6.9

2.6

1.3

2.1

e6/l

—

(3007164) IgA [Mass/volume] in Serum or Plasma

103

4.33

5.91

1.8

1.3

3.1

2.2

g/l

1.82

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

15.40

5.84

1.8

1.3

0.0

g/l

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

13.46

5.55

1.3

1.5

—

(36304419) Bacteria [Presence] in Urine

102

4.03

5.35

10.3

2.6

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

124

4.02

5.32

11.3

3.3

34.6

36.1

g/l

0.65

118

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

6.39

5.29

4.0

1.5

—

(3018095) Leukocytes [#/volume] in Urine

135

3.90

5.06

13.0

3.1

9.1

26.9

e6/l

1.50

(3030467) Casts [#/volume] in Urine by Automated count

101

3.75

4.81

10.5

2.6

0.1

0.4

e6/l

1.13

(3009343) pH of Capillary blood

5.75

4.77

9.8

7.2

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

5.75

4.77

9.8

7.2

4.9

5.0

kpa

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

16.02

4.73

1.4

1.2

—

(3037756) Immunofixation for Serum or Plasma

16.02

4.73

1.3

1.0

—

(3013707) Erythrocyte sedimentation rate by Westergren method

262

4.86

4.64

9.5

3.5

14.9

9.3

mm/h

1.17

245

(3000850) Epithelial cells [#/volume] in Urine

3.74

4.53

8.9

2.3

3.0

7.2

e6/l

1.84

(3021879) Hepatitis B virus core Ab [Presence] in Serum

4.20

4.11

1.2

1.5

—

(40768443) Skin Pathology biopsy report

7.10

4.03

1.1

1.3

—

(3000991) Gas panel - Venous blood

4.46

3.89

8.5

5.2

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

7.74

3.85

5.0

2.1

98.3

87.3

—

(3026782) Osmolality of Urine

3.40

3.75

10.3

2.3

591.3

559.3

mosm/kgh2o

0.22

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

7.13

3.67

13.9

6.6

1.0

1.1

mg/l

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

3.35

3.66

1.4

1.5

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

132

3.12

3.63

12.1

4.9

1.2

mmol/l

0.51

122

(3022313) Gas panel - Capillary blood

5.57

3.43

12.2

6.2

—

(3007853) Bacteria identified in Skin by Aerobe culture

3.67

3.24

2.1

1.8

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

4.78

3.06

14.6

3.9

236.9

211.4

u/l

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

10.94

3.04

1.2

1.0

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

10.94

3.04

1.0

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

7.42

2.96

6.2

2.1

3.0

3.8

g/l

—

(3023368) Bacteria identified in Blood by Culture

2.98

2.86

4.8

3.8

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

6.67

2.78

1.5

1.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

2.71

2.35

1.7

—

(3026493) Urate [Moles/volume] in Serum or Plasma

2.71

2.35

2.7

2.8

383.7

341.8

umol/l

0.84

(3037467) Urinalysis macro (dipstick) panel - Urine

273

2.88

2.34

12.9

3.5

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

2.53

2.29

7.5

3.0

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

6.05

2.27

1.2

2.1

—

(3012544) pH of Venous blood

3.15

2.26

8.0

3.1

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

3.63

2.21

5.6

4.3

23.0

24.9

mmol/l

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

3.06

2.17

8.0

3.0

5.5

5.7

kpa

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

5.43

2.12

1.0

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

4.41

2.11

1.0

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

4.41

2.11

1.2

1.3

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

4.12

2.00

1.8

3.2

—

(3015736) pH of Urine

147

2.27

2.00

5.7

2.7

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

3.54

1.96

1.1

1.8

—

(3045414) Leukocytes [Presence] in Urine

3.88

1.90

1.7

1.6

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2.99

1.82

1.0

1.7

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

3.65

1.81

4.7

1.7

0.1

e6/l

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

3.65

1.81

1.2

1.4

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2.79

1.68

1.0

1.7

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

140

2.05

1.58

3.4

2.0

64.1

76.3

nmol/l

0.94

123

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2.48

1.52

3.9

1.8

—

(4035726)

2.83

1.41

1.2

1.1

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

102

2.03

1.40

3.4

2.2

2.3

2.4

mmol/l

0.73

(3042936) Bacteria identified in Isolate by Culture

2.62

1.37

3.1

2.5

—

(3026008) Bacteria identified in Urine by Culture

1.97

1.27

5.6

2.2

—

(3008898) HLA-B27 [Presence]

2.81

1.25

1.2

1.1

—

(40761535) Cells panel - Urine sediment

2.49

1.23

5.3

2.7

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

170

0.48

1.21

8.3

3.6

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

116

1.88

1.19

1.4

1.3

1.1

1.5

u/ml

—

(40768797) Stomach Pathology biopsy report

2.14

1.15

1.4

1.2

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2.12

1.10

3.7

2.6

3.9

7.8

umol/l

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

120

1.80

1.06

2.0

2.1

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

103

1.83

1.05

1.6

1.7

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1.99

0.96

2.9

3.6

16.9

23.9

—

(3019225) pH of Specimen

2.22

0.93

11.5

3.3

—

(3000494) Fungus identified in Specimen by Culture

2.07

0.88

6.0

1.4

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.93

0.82

1.0

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

352

1.82

0.78

20.6

8.4

91.2

89.8

ml/min/173m2

0.14

258

(3022145) Colonoscopy Study observation

1.93

0.76

1.6

1.2

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1.68

0.73

1.8

2.1

1.4

mmol/l

0.60

(3005033) Fetal Nuchal fold Thickness US

0.00

0.62

0.0

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.00

0.62

0.0

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.00

0.62

0.0

1.5

—

(3024354) Oxygen [Partial pressure] in Venous blood

1.81

0.60

11.8

3.2

7.2

5.1

kpa

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1.65

0.58

1.4

1.3

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

111

1.51

0.55

2.5

1.6

77.8

94.3

pmol/l

—

(3002385) Erythrocyte distribution width [Ratio]

353

1.56

0.52

30.2

10.9

13.7

13.3

1.17

345

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

358

0.68

0.51

4.8

3.9

1.9

mu/l

0.18

327

(46235355) HIV 1 and 2 tests - Meaningful Use set

133

1.43

0.47

2.3

2.2

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1.47

0.47

4.0

2.5

2.4

mmol/l

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

143

1.41

0.46

5.1

3.0

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1.51

0.46

3.5

4.2

—

(4010399)

1.68

0.44

1.4

1.3

—

(3020961) Endomysium IgA Ab [Titer] in Serum

1.68

0.44

1.2

1.3

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

0.42

0.0

1.5

—

(3028707) Methadone [Presence] in Urine by Screen method

0.00

0.42

0.0

2.3

—

(3044889) 12 lead EKG panel

233

1.36

0.41

2.5

3.0

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1.48

0.40

3.8

4.4

25.4

30.9

—

(3044640) Blood type and Crossmatch panel - Blood

103

1.36

0.32

5.5

1.9

—

(3041096) Erythrocytes [Presence] in Urine by Automated

104

1.34

0.30

3.4

2.6

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

0.71

0.25

1.9

2.5

—

(3000492) Spirometry study

1.24

0.23

1.2

—

(40768793) Breast Pathology biopsy report

0.00

0.21

0.0

1.2

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

0.00

0.21

0.0

1.0

—

461.4

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

0.00

0.21

0.0

1.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

0.78

0.15

2.0

2.9

—

(1761868) Lipid panel - Serum or Plasma

126

1.16

0.10

2.1

2.7

—

(36660697) Celiac disease serology panel - Serum

1.12

0.10

1.2

1.1

—

(3013512) EKG study

0.84

0.08

3.6

3.7

—

(3019832) Treponema pallidum Ab [Presence] in Serum

0.84

0.07

1.6

1.8

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

317

0.94

0.02

3.9

3.8

—

(3003694) ABO and Rh group [Type] in Blood

119

1.01

0.00

1.5

1.4

—

(40768804) Tissue Pathology biopsy report

115

1.06

0.00

2.1

1.8

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.00

0.0

1.5

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

0.00

0.0

1.7

—

329.7

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.2

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

0.88

0.00

8.0

1.8

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

5.2

—

213.6

—

(3016244) Insulin [Units/volume] in Serum or Plasma

0.00

0.0

2.4

—

6.4

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

0.00

0.0

3.6

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

0.00

0.0

3.4

—

3.8

—

(3035637) Corticotropin [Mass/volume] in Plasma

0.00

0.0

1.3

—

(3026389) Candida sp identified in Specimen by Organism specific culture

0.00

0.0

1.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

0.00

0.0

1.2

—

(3044290) Cell count panel - Cerebral spinal fluid

0.00

0.0

2.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.00

0.0

2.0

—

(3025130) Human papilloma virus identified in Specimen

0.00

0.0

2.0

—

(4094501)

0.00

0.0

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.00

0.0

1.0

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

0.3

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

0.00

0.0

1.6

—

21.7

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

0.00

0.0

1.7

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

0.00

0.0

1.0

—

106.0

—

(40768800) Prostate Pathology biopsy report

0.00

0.0

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

0.00

0.0

1.0

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

0.0

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

0.00

0.0

1.7

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

2.0

—

17.3

—

(3039443) Prostate specific Ag panel - Serum or Plasma

0.00

0.0

1.6

—

(3023410) Appearance of Cerebral spinal fluid

0.00

0.0

2.5

—

Mortality – FinRegistry

↥

Association

Association between endpoint ARTHROPATHY_HYPERSENS and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have ARTHROPATHY_HYPERSENS.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: ARTHROPATHY_HYPERSENS – Arthropathy in hypersensitivity reactions classified elsewhere

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Arthropathy in hypersensitivity reactions classified elsewhere

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints